This article first appeared with Targeted Oncology™. An orphan drug designation (ODD) was granted by the FDA to elraglusib for the treatment of patients with soft tissue sarcoma (STS). 1 Currently, a ...

Complete Title: A randomized study comparing the efficacy of the combination of doxorubicin and the tumor-targeting human antibody-cytokine fusion protein L19TNF to doxorubicin alone as first-line ...

Soft tissue sarcomas are a group of rare cancers that can occur in almost any part of the body and develop in tissues like muscle, fat, and nerves. The most common types are leiomyosarcoma, ...

Aristolochic acid (AA) exposure and telomere maintenance mechanism in liver angiosarcoma (AS). Efficacy and safety of anlotinib combined with anthracycline and ifosfamide followed by anlotinib ...

Ravin Ratan, MD, MEd, of The University of Texas MD Anderson Cancer Center, explains the origins of soft tissue sarcomas within the body—which account for 1% of cancers in adult patients—how they are ...

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleucel (Tecelra ®, also known as afami-cel) for the treatment of adults with a rare ...

Undifferentiated small round cell sarcoma (USRCS) is a type of cancer affecting the bones and soft tissue. This rare form of cancer can affect people of all ages. USRCS is an extremely rare sarcoma ...

Lumps and bumps are common in childhood, but when they form in soft tissue without an obvious cause, they could be pediatric soft tissue sarcoma (STS). In children, cancer that forms in the soft ...